{"id":"NCT01371838","sponsor":"Pfizer","briefTitle":"A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia","officialTitle":"A Phase III, Multicentre, Randomised, Double-Blind, Comparative Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-12","primaryCompletion":"2013-05","completion":"2013-05","firstPosted":"2011-06-13","resultsPosted":"2014-09-23","lastUpdate":"2017-09-06"},"enrollment":848,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Community-Acquired Bacterial Pneumonia","Lung Infection of Individual Not Recently Hospitalized"],"interventions":[{"type":"DRUG","name":"Ceftaroline","otherNames":[]},{"type":"DRUG","name":"Ceftriaxone","otherNames":[]}],"arms":[{"label":"Ceftaroline","type":"EXPERIMENTAL"},{"label":"Ceftriaxone plus placebo","type":"ACTIVE_COMPARATOR"}],"summary":"This purpose of this study is to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia.","primaryOutcome":{"measure":"Clinical Cure Rate for Ceftaroline Compared to That for Ceftriaxone at Test of Cure (TOC) in CE Population","timeFrame":"7-20 days after last dose of study drug","effectByArm":[{"arm":"Ceftaroline 600mg","deltaMin":217,"sd":null},{"arm":"Ceftriaxone 2g","deltaMin":178,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":43,"countries":["China","India","South Korea","Taiwan","Vietnam"]},"refs":{"pmids":["35237053","34922058","31044546","30597021","30380060","26702925","25539586"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=1374&filename=D3720C00002_Synopsis.pdf","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=1374&filename=D3720C00002_Revised_CSP_1_(redacted).pdf"]},"adverseEventsSummary":{"seriousAny":{"events":30,"n":381},"commonTop":["DIARRHOEA"]}}